(FILES) In this file photo taken on August 13, 2021 a health worker prepares a jab of the Pfizer-BioNtech Covid-19 vaccine at the Cau Hansen's Event Center, located in the city of Joinville, state of Santa Catarina, Brazil. - Brazil's health regulator approved the Pfizer-BioNTech Covid-19 vaccine on December 16, 2021 for use in children aged five to 11, clearing the way for the hard-hit country to join the growing list of those extending vaccination to kids. (Photo by Carlos  JUNIOR / AFP)
(FILES) In this file photo taken on August 13, 2021 a health worker prepares a jab of the Pfizer-BioNtech Covid-19 vaccine at the Cau Hansen's Event Center, located in the city of Joinville, state of Santa Catarina, Brazil. - Brazil's health regulator approved the Pfizer-BioNTech Covid-19 vaccine on December 16, 2021 for use in children aged five to 11, clearing the way for the hard-hit country to join the growing list of those extending vaccination to kids. (Photo by Carlos JUNIOR / AFP)
/ CARLOS JUNIOR
Por Redacción EC

Han pasado dos años desde que el SARS-CoV-2, virus que causa el COVID-19, surgió. Hoy, dos años después, tenemos diversas de sus variantes circulando en el mundo, la última de ellas y la que genera preocupación es Ómicron.

Conforme a los criterios de

Trust Project
Tipo de trabajo: